Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2000

View Archived Issues

Barr submits IND for Seasonale oral contraceptive

Phase I/II results for oral candidiasis treatment for HIV/AIDS patients

CytoTherapeutics changes name to StemCells

Immtech's DB-289 proves effective against African sleeping sickness

Maxim sells MaxVax mucosal vaccine technology

Progenics to continue GMK cancer vaccine trial as an extension study

BLS initiates inosine development program as stroke therapy

Guilford signs definitive merger agreement with Gliatech

TOBI trial in young CF patients with mild lung disease commences; European patent granted

Repligen acquires U.S. patent rights to CTLA4-Ig

Olux approved for U.S. marketing

PI-88 under development for cardiovascular indication; Progen enters strategic alliance

Xenova releases data from phase II colorectal cancer trial

Bayer decides to discontinue development of Bay-44-3428 for asthma

Development progresses for Nuvance in the treatment of asthma

Alizyme acquires renzapride, receives equity investment from SmithKline Beecham

In vitro and clinical data for daptomycin presented at ECCMID; Cubist accelerates development

Efforts to develop malaria vaccines reviewed at ECCMID; new candidate from SB highlighted

Merck carbapenem continues to yield positive results in preclinical and clinical studies

No efficacy seen for 9-AC in phase II trial in AIDS-related KS

Visudyne therapy receives Canadian approval for treatment of wet AMD

Use of pregabalin and related compounds for mania and bipolar disorder

BDNF reported to be useful for liver diseases

Antibodies to von Willebrand factor that act only at sites of thrombus formation

Joint research at Novo Nordisk and Dr. Reddy's covered by multiple patents

Natural protein with the ability to abrogate certain toxic effects of TNF

Novel class of inhibitors of cysteine proteases of the ICE/ced-3 family designed by Idun

Sagami discovers antitumor lipopeptides produced by fungus

Inhibitors of nitric oxide synthase synthesized at Schering AG

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...